MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Type A Meeting with FDA, page-470

  1. 16,584 Posts.
    lightbulb Created with Sketch. 8092
    Ahaha.

    For 15 years there's always been someone or something to blame for MSB's woes.
    This time I see its the FDA who is accused of eating MSB's homework.

    I guess if MSB's creditors start to get antsy with the company, which forces an unfavourable outcome, then they will replace the FDA as the evil bogeyman.

    .
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.